Neuralink plans to expand rapidly by implanting brain chips in 20,000 people annually by 2031 with an anticipated $1 billion revenue. The company will open five clinics to streamline processes from patient evaluation to post-operative care. Currently, it has conducted limited human trials with the N1 implant, which allows users to control devices. Future goals include addressing blindness, neurological disorders, and possibly enhancing human cognition. This growth requires significant advancements in technology and public compliance, marking a departure from existing operational scales.
Neuralink projects to implant brain chips in 20,000 people annually by 2031, aiming for $1 billion in revenue and five large clinics to support growth.
The company seeks to create a streamlined infrastructure for patient management, reducing bottlenecks and enhancing efficiency in carrying out procedures.
Neuralink's N1 implant interprets neural signals to control external devices, while future versions aim to restore vision, treat neurological disorders, and enhance cognition.
Noland Arbaugh, a quadriplegic patient, exemplifies Neuralink's potential as he can now control a computer cursor with his mind through the brain chip.
Collection
[
|
...
]